144 related articles for article (PubMed ID: 31106107)
1. Alleviation of low-fiber diet-induced constipation by probiotic
Makizaki Y; Maeda A; Oikawa Y; Tamura S; Tanaka Y; Nakajima S; Yamamura H
Biosci Microbiota Food Health; 2019; 38(2):49-53. PubMed ID: 31106107
[TBL] [Abstract][Full Text] [Related]
2. Improvement of loperamide-induced slow transit constipation by Bifidobacterium bifidum G9-1 is mediated by the correction of butyrate production and neurotransmitter profile due to improvement in dysbiosis.
Makizaki Y; Uemoto T; Yokota H; Yamamoto M; Tanaka Y; Ohno H
PLoS One; 2021; 16(3):e0248584. PubMed ID: 33750988
[TBL] [Abstract][Full Text] [Related]
3. Probiotic Bifidobacterium bifidum G9-1 attenuates 5-fluorouracil-induced intestinal mucositis in mice via suppression of dysbiosis-related secondary inflammatory responses.
Kato S; Hamouda N; Kano Y; Oikawa Y; Tanaka Y; Matsumoto K; Amagase K; Shimakawa M
Clin Exp Pharmacol Physiol; 2017 Oct; 44(10):1017-1025. PubMed ID: 28590519
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of
Fuyuki A; Higurashi T; Kessoku T; Ashikari K; Yoshihara T; Misawa N; Iwaki M; Kobayashi T; Ohkubo H; Yoneda M; Usuda H; Wada K; Nakajima A
Biosci Microbiota Food Health; 2021; 40(2):105-114. PubMed ID: 33996367
[TBL] [Abstract][Full Text] [Related]
5. Probiotic Bifidobacterium bifidum G9-1 ameliorates phytohemagglutinin-induced diarrhea caused by intestinal dysbiosis.
Makizaki Y; Maeda A; Oikawa Y; Tamura S; Tanaka Y; Nakajima S; Ohno H; Yamamura H
Microbiol Immunol; 2019 Dec; 63(12):481-486. PubMed ID: 31544979
[TBL] [Abstract][Full Text] [Related]
6. Oral administration of Bifidobacterium bifidum G9-1 alleviates rotavirus gastroenteritis through regulation of intestinal homeostasis by inducing mucosal protective factors.
Kawahara T; Makizaki Y; Oikawa Y; Tanaka Y; Maeda A; Shimakawa M; Komoto S; Moriguchi K; Ohno H; Taniguchi K
PLoS One; 2017; 12(3):e0173979. PubMed ID: 28346473
[TBL] [Abstract][Full Text] [Related]
7. Corrigendum: Alleviation of low-fiber diet-induced constipation by probiotic
Biosci Microbiota Food Health; 2021; 40(4):212. PubMed ID: 34631333
[TBL] [Abstract][Full Text] [Related]
8. Effects of probiotic Bifidobacterium bifidum G9-1 on the gastrointestinal symptoms of patients with type 2 diabetes mellitus treated with metformin: An open-label, single-arm, exploratory research trial.
Hata S; Nakajima H; Hashimoto Y; Miyoshi T; Hosomi Y; Okamura T; Majima S; Nakanishi N; Senmaru T; Osaka T; Okada H; Ushigome E; Hamaguchi M; Asano M; Yamazaki M; Fukui M
J Diabetes Investig; 2022 Mar; 13(3):489-500. PubMed ID: 34665938
[TBL] [Abstract][Full Text] [Related]
9.
Makizaki Y; Maeda A; Yamamoto M; Tamura S; Tanaka Y; Nakajima S; Ohno H
Biosci Microbiota Food Health; 2020; 39(3):145-151. PubMed ID: 32775133
[TBL] [Abstract][Full Text] [Related]
10. Effect of probiotic Bifidobacterium bifidum G9-1 on the relationship between gut microbiota profile and stress sensitivity in maternally separated rats.
Fukui H; Oshima T; Tanaka Y; Oikawa Y; Makizaki Y; Ohno H; Tomita T; Watari J; Miwa H
Sci Rep; 2018 Aug; 8(1):12384. PubMed ID: 30120330
[TBL] [Abstract][Full Text] [Related]
11. Effect of probiotics,
Hashimoto Y; Nakajima H; Hata S; Miyoshi T; Hosomi Y; Majima S; Nakanishi N; Senmaru T; Osaka T; Okada H; Ushigome E; Hamaguchi M; Asano M; Yamazaki M; Fukui M
J Clin Biochem Nutr; 2020 Nov; 67(3):223-227. PubMed ID: 33293761
[TBL] [Abstract][Full Text] [Related]
12. Protocol of efficacy of bifidobacteria intake on gastrointestinal symptoms in symptomatic type 2 diabetes mellitus patients in abdominis: An open-label, randomized controlled trial (Binary STAR study).
Hashimoto Y; Kobayashi G; Kitagawa N; Okada H; Hamaguchi M; Fukui M
PLoS One; 2024; 19(1):e0295998. PubMed ID: 38206908
[TBL] [Abstract][Full Text] [Related]
13. Effect of
Tomita T; Fukui H; Okugawa T; Nakanishi T; Mieno M; Nakai K; Eda H; Kitayama Y; Oshima T; Shinzaki S; Miwa H
J Clin Med; 2023 May; 12(10):. PubMed ID: 37240476
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal study of effects of oral dosage of Bifidobacterium bifidum G9-1 on Japanese cedar pollen-induced allergic nasal symptoms in guinea pigs.
Tsunemine S; Isa Y; Ohno H; Hagino S; Yamamura H; Mizutani N; Nabe T
Microbiol Immunol; 2015 Nov; 59(11):690-9. PubMed ID: 26400839
[TBL] [Abstract][Full Text] [Related]
15. Effects of Bifidobacterium bifidum G9-1 on Nasal Symptoms in a Guinea Pig Model of Experimental Allergic Rhinitis.
Tsunemine S; Isa Y; Shimakawa M; Ohno H; Yamamura H
Biosci Microflora; 2011; 30(1):1-7. PubMed ID: 25045310
[TBL] [Abstract][Full Text] [Related]
16. The protective effect of
Yoshihara T; Oikawa Y; Kato T; Kessoku T; Kobayashi T; Kato S; Misawa N; Ashikari K; Fuyuki A; Ohkubo H; Higurashi T; Tateishi Y; Tanaka Y; Nakajima S; Ohno H; Wada K; Nakajima A
Gut Microbes; 2020 Sep; 11(5):1385-1404. PubMed ID: 32515658
[TBL] [Abstract][Full Text] [Related]
17. Oral administration of Bifidobacterium bifidum G9-1 suppresses total and antigen specific immunoglobulin E production in mice.
Ohno H; Tsunemine S; Isa Y; Shimakawa M; Yamamura H
Biol Pharm Bull; 2005 Aug; 28(8):1462-6. PubMed ID: 16079493
[TBL] [Abstract][Full Text] [Related]
18. Lactobacillus gasseri KS-13, Bifidobacterium bifidum G9-1, and Bifidobacterium longum MM-2 Ingestion Induces a Less Inflammatory Cytokine Profile and a Potentially Beneficial Shift in Gut Microbiota in Older Adults: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study.
Spaiser SJ; Culpepper T; Nieves C; Ukhanova M; Mai V; Percival SS; Christman MC; Langkamp-Henken B
J Am Coll Nutr; 2015; 34(6):459-69. PubMed ID: 25909149
[TBL] [Abstract][Full Text] [Related]
19.
Tang N; Yu Q; Mei C; Wang J; Wang L; Wang G; Zhao J; Chen W
Nutrients; 2023 Feb; 15(5):. PubMed ID: 36904145
[TBL] [Abstract][Full Text] [Related]
20. Probiotic
Wang X; Fukui H; Ran Y; Xu X; Ebisutani N; Nakanishi T; Tanaka Y; Maeda A; Makizaki Y; Tomita T; Oshima T; Miwa H
Biomedicines; 2021 Jun; 9(6):. PubMed ID: 34204993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
